A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
D-Dimer, Plasma
Test CodeDDIQ - NOCO
CPT Codes
85379
Preferred Specimen
1.0 mL plasma from Blue Top (3.2% Na Citrate)
Minimum Volume
Full blue top tube or 1.0 mL plasma frozen
Instructions
- It is imperative that the tube be completely filled to frosted line. The ratio of blood to anticoagulant is critical for valid coagulation results. If obtaining blood with a syringe, fill the light blue-top (sodium citrate) tube first.
- If patient is on heparin, specimen must be centrifuged and separated within 1 hour of draw.
- Heparin contaminated tube is not acceptable.
- Keep specimen anaerobic.
- Patients with an extremely high hematocrit may require special tubes before obtaining blood for coagulation testing. Please contact the lab for further information.
- If testing will not be completed within 4 hours, spin down, remove plasma, and spin plasma again, and send specimen frozen in plastic vial.
Specimen Stability
Specimen Type | Temperature | Time |
Whole blood Na Cit on heparin | Ambient | 1 hour |
Whole blood Na Cit (unopen/unspun) | Ambient | 4 hours |
Plasma Na Cit (unopen/spun) | Ambient | 4 hours |
Plasma Na Cit double spun and separated | Frozen -20 C | 2 weeks |
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Clotted Serum received instead of Sodium Citrate plasma
Specimen past stability
Frozen plasma received thawed
Underfilled or Overfilled, blood/anticoagulant ratio must be 9/1; Specimens must be between 90% -110% full
Collected in a 3.8% Sodium Citrate tube instead of 3.2% Sodium Citrate tube
Drawn in outdated/expired tube
Hemolyzed, icteric, or lipemic sample
Specimen past stability
Frozen plasma received thawed
Underfilled or Overfilled, blood/anticoagulant ratio must be 9/1; Specimens must be between 90% -110% full
Collected in a 3.8% Sodium Citrate tube instead of 3.2% Sodium Citrate tube
Drawn in outdated/expired tube
Hemolyzed, icteric, or lipemic sample
Methodology
Immunoturbidometric
Setup Schedule
Monday through Sunday; Continuously
Report Available
Same day
Reference Range
0.27 - 0.49 ug/mL
Clinical Significance
The determination of D-Dimer is becoming a widespread tool for diagnosing thrombosis and monitoring thrombolytic therapy.
Elevated levels of D-Dimer are found in clinical conditions such as deep vein thrombosis (DVT, pulmonary embolism (PE) and disseminated intravascular coagulation (DIC). D-Dimer levels also rise during the normal pregnancy, but very high levels are associated with complications. A negative D-Dimer result when combined with a clinical assessment of low pretest probability has been shown to have a high negative predictive value for DVT or PE. D-Dimer results in human citrated plasma from IL Coagulation systems in conjunction with a clinical pretest probability (PTP) assessment model can exclude venous thromboembolism in outpatients suspected of deep venous thrombosis and pulmonary embolism.
While a positive D-Dimer alone is not diagnostic of DVT or PE, a negative D-Dimer can be used to exclude the diagnosis of venous thrombosis. There are a number of articles available that discuss the choice of cut-off value for ruling out venous thrombosis.
Elevated levels of D-Dimer are found in clinical conditions such as deep vein thrombosis (DVT, pulmonary embolism (PE) and disseminated intravascular coagulation (DIC). D-Dimer levels also rise during the normal pregnancy, but very high levels are associated with complications. A negative D-Dimer result when combined with a clinical assessment of low pretest probability has been shown to have a high negative predictive value for DVT or PE. D-Dimer results in human citrated plasma from IL Coagulation systems in conjunction with a clinical pretest probability (PTP) assessment model can exclude venous thromboembolism in outpatients suspected of deep venous thrombosis and pulmonary embolism.
While a positive D-Dimer alone is not diagnostic of DVT or PE, a negative D-Dimer can be used to exclude the diagnosis of venous thrombosis. There are a number of articles available that discuss the choice of cut-off value for ruling out venous thrombosis.
Performing Laboratory
Banner Fort Collins Medical Center Laboratory
Mckee Medical Center Laboratory
North Colorado Medical Center Laboratory
Summit View Laboratory